Principles of Pharmacokinetics
|
|
- Ross Harmon
- 6 years ago
- Views:
Transcription
1 Principles of Pharmacokinetics Ákos Csomós MD, PhD Associate Professor Institute of Anaesthesia and Critical Care, Semmelweis University, Budapest, Hungary
2 Pharmacokinetics: Very basics How the organ affects the drug: 1) Absorption 2) Distribution 3) Metabolism 4) Elimination Pharmacodynamics: How the drug affects the organ: Direct effect (inhalational anaesthetics) Receptor effect (H 2 antagonists) Enzymes (neostigmine)
3 Pharmacokinetics
4 1. Absorption of drugs Diffusion (for most drugs), which depends on: Solubility Tissue permeability (in relation to ph) Surface area Regional blood supply GI system: Motility, enzyme effect First pass metabolism Lungs (inhalational agents): Cardiac output and respiratory minute volume
5 2. Distribution of drugs Lipid solubility pk: ionisation of drug low pk = stronger acid Total body ph Protein binding Albumin binding: thiopentone, warfarin, salycilates Reduces the proportion and availability of free drug Volume of distribution and clearance is inversely proprotional to protein binding Regional blood distribution Redistribution from blood: Compartment models
6 2. One compartment model Dose V d Elimination
7 2. What is volume of distribution (V d )? It is the volume of water, in which the drug is distributed for the measured plasma concentration. Drug distribution in plasma only: V d = blood volume Drug distribution in total body: V d = total body water Average volumes (for 70 kg): V d = dose concentration Digoxin Propranolol Lidocaine Aspirin Warfarin 500 l 250 l 120 l 12 l 9 l
8 3. Durg metabolism (=kinetics) ZERO ORDER the metabolism is constant (=the same amount is metabolized in a given time, independently of plasma concentration (Cp) FIRST ORDER the metabolism depends on the plasma concentration (=the same proportion is metabolized in a given time)
9 3. Elimination curves ZERO ORDER FIRST ORDER
10 Three compartment model
11 Three compartment model
12 Definittion of different compartments V1 CENTRAL COMPARTMENT (Vc): into which the drug is injected, e.g. blood, lungs, cerebrospinal fluid (~brain) V2 PERIPHERAL COMPARTMENT (vessel-rich, fast redistribution): e.g. muscle tissue, extracellular space V3 PERIPHERAL COMPARTMENT (vessel-poor, slow): e.g. fat tissue IMPORTANT! These are theoretical volumes, can NOT be attributed to any anatomical or physiological structures.
13 Analogue of a three compartment model
14 Original DIPRIFUSOR compartment model Launched: December 1999 (!)
15 Original DIPRIFUSOR compartment model Each values were calculated by a computer simulation program: Volume of V1: 228 ml/kg Distribution constants between compartments: k12 = /min k21 = /min k13 = /min k31 = /min Elimination constant from V1: /min Age was NOT used by this model ( ) MARSH model
16 Changes of propofol plasma concentration in a three compartment model
17 10 minutes vs. 3 hours infusion No equilibration V1 = V2 = V3 Reduction in plasma level is determined by redistribution Reduction in plasma level is determined by elimination
18 4. Half-time (T 1/2 ) The time required for a given concentration value to be reduced to its half. The reduction is exponential, which is best described by the time constant (τ): 1τ = 63 %, 2τ = 86,5 %, 3τ = 95 %, 4τ = 99,75%. T 1/2 = k Redistribution half-time vs. elimination half time? None of these expresses the drug kinetics in practice.
19 4. Context-sensitive half time (CSHT) Context-sensitive half time (CSHT): the time required to half the plasma concentration after stopping an intravenous infusion of a drug. The context is the volume of infusion. After steady-state condition reached, the half time will become context insensitive. 2 hours 6 hours 9 hours Propofol 20 min 30 min 50 min Alfentanil 40 min 70 min 80 min Fentanyl 40 min 4 hrs 5 hrs
20 Distribution of 10 minutes infusion Redistribution to V3 is minimal. There is no steady state condition. After stopping the infusion, redistribution is higher in proportion than elimination. CSHT value is closer to redisribution halftime.
21 Distribution of 3 hours infusion More drug reaches the peripheral (V3) compartment; distibution is equalized to steady state condition: V1 = V2 = V3. There is no redistribution after stopping the infusion, the reduction in plasma level is determined by elimination. CSHT value is closer to elimination halftime.
22 (min) CSHT vs. elimination half time CSHT ( perc) = Elimination half-time 1 perc min 1 óra hr 3 óra hrs 8 óra hrs S-state 0 Alfent. Midaz. Propof. Thiop. Fent. Sufent.
23 Context-sensitive half time Where is remi??
24 ASA I. healthy volunteers were given infusion of alfentanil (n=15) and remifentanil (n=15) for 3 hours. Context-sensitive half times (50% reduction): Alfentanil: 47.3 ±12 min. Remifentanil: 3.2 ±0.9 min. Terminal elimination half times: Alfentanil: 76.5 ±12.6 min. Remifentanil: 11.8 ±5.1 min.
25 Use of CSHT in every day clinical practice Reduction of interavenous drug concentration is best described by CSHT. Clinical use is most often modelled by comparing10 minutes and 3 hours infusion. Drug injection and elimination is from the central compartment. NB: elimination is only from the central compartment.
26 Pharmacokinetics of commonly used iv. anaesthetics, comparing 10 min and 3 hours infusion CSHT (min) V d (litre/kg) Redistr. T 1/2 (min) Elimin. T 1/2 Clearance (ml/min/kg) Remifentanil 3 / / 0.4 0,5 / 1,5 8 / 20 min 40 / 60 Alfentanil 10 / / / 3 1 / 2 hrs 3 / 8 Sufentanil 14 / 20 / 11 Fentanyl 12 / 70 3 / 5 1 / 2 3 / 5 hrs 10 / 20 Propofol 5 / 9 2 / 10 1 / 4 4 / 7 hrs 20 / 30 Thiopentone 4 / / / 7 5 / 18 hrs 3-4
27 Pharmacokinetics of TIVA vs. TCI
28 Differences expressed by measuring units Total Intravenous Anaesthesia (TIVA): Propofol administration: mg/hour Target Controlled Infusion (TCI): Propofol administration: µg/ml
29 Why do we need TCI?
30 TCI target concentration and speed of administration Propofol blood concentration 1. TCI start 2. Target: 6 µg/ml 3. Target: 4 µg/ml 4. Target: 6 µg/ml 5. TCI stop Propofol speed of admin.
31 Differences between propofol TCI models MARSH 70 kg patient SCHNIDER 70 kg patient V l/kg 15.9 l 4.27 l 4.27 l V l/kg 32.4 l x (age-53) litre 24 l V l/kg l 238 l 238 l Marsh model calculates higher V1 volume. Schnider model uses constant V1 volume. Considerable difference exist in bolus administration!
32 How much do you weigh?
33 What body weight would you use? There are two patients, both 170 cm tall; one weights 160 kg, the other is 80 kg. Would you give twice as much propofol? There are two patients, both weight 100 kg; however, there is 50 cm difference in body height. Would you give the same amount of propofol?
34 Which body weight should be used for TIVA/TCI? Determining the appropriate body weight is crucial in TIVA/TCI (for Vd). Most pharmacokinetic studies were done in healthy patients: there are no data in obesity, liver disease and elderly. Even remifentanil has been reported to overdose in obese (Egan, 1998) There was a good correlation between lean body mass and dose of propofol.
35 Lean body mass =? Schnider model (propofol) and the Minto model (remifentanil) uses this formula: MALE: LBM = 1,1 x weight 128 x (wight/height) 2 FEMALE: LBM = 1,07 x weight 148 x (weight/height) 2 It is not good for extreme obesity. Solution? There is a maximum body weight in each TCI pump, above which it does not work.
36 Calculating body weight LBM: Ideal body weight: 170 cm, 80 kg: kg kg 170 cm, 160 kg: kg kg 200 cm, 100 kg: 78 kg kg 150 cm, 100 kg: kg kg Calculations: LBM (male) = 1.1 x bodyweight 128 x (bodyweigh/height) 2 IBW (male) = x (body height 152.4)
37 TTPE and k eo
38 TTPE TTPE = Time To Peak Effect = Time required for the plasma and effect site concentration curves to cross each other. Independent of bolus dose.
39 Time to peak effect (TTPE)
40 k eo k eo = rate constant, which describes the speed of drug distribution between V1 compartment and effect site compartment. Individual k eo for each anaesthetics. It is required when using TCI effect-site concentration for target.
41 k eo in a three compartment model The effect site is considered to have no volume, so the rate constant for movement into and out of this compartment is the same (K1e=Keo).
42 How did they calculate the propofol k eo value? MARSH model used AEP monitor to determine the effect of propofol; k eo = 0,26. Modified MARSH model (Struys) use different k eo value = 1,2. SCHNIDER model used EEG monitor; k eo = 0,456. There is no consensus on which one is better
43 Effect-site or plasma concentration. Which is better? Age-related difference is bigger in effect site
44 Decrement time
45 Decrement time Definition: the required time to reach a given lower plasma concentration. It is calculated by the TCI model; helps in estimating the awakening time of the patient. Awakening plasma concentration (=decrement concentration) is set by the user; normally 1-2 µg/ml
46 What is shown in a TCI pump display?
47 Do we have evidence that TCI is better?
48 20 trials of poor quality were included (n=1759). Heterogeneity was very high. TCI was associated with higher total propofol dose, and marginally higher propofol costs. However, fewer interventions were required by the anaesthetist during TCI. No significant differences in quality of anaesthesia and adverse events.
49 Thanks for your attention!
Pharmacokinetics of drug infusions
SA Hill MA PhD FRCA Key points The i.v. route provides the most predictable plasma concentrations. Pharmacodynamic effects of a drug are related to plasma concentration. Both plasma and effect compartments
More informationBasic pharmacokinetics. Frédérique Servin APHP hôpital Bichat Paris, FRANCE
Basic pharmacokinetics Frédérique Servin APHP hôpital Bichat Paris, FRANCE DOSE CONCENTRATION EFFECT Pharmacokinetics What the body does to the drug Pharmacodynamics What the drug does to the body Transfer
More informationSign up to receive ATOTW weekly Regarding the use of propofol in total intravenous anaesthesia:
TARGET CONTROLLED INFUSIONS IN ANAESTHETIC PRACTICE ANAESTHESIA TUTORIAL OF THE WEEK 75 26th NOVEMBER 2007 Dr Subash Sivasubramaniam University Hospitals of North Staffordshire subashken@yahoo.com SELF
More informationPharmacology in the obese : does weight matter?
A A Pharmacology in the obese : does weight matter? Michel MRF Struys, MD, PhD Professor and Chair, Department of Anesthesia University Medical Center Groningen Groningen, The Netherlands Professor of
More informationPharmacokinetic models for propofol defining and illuminating the devil in the detail
British Journal of Anaesthesia 13 (1): 26 37 (29) doi:1.193/bja/aep143 Advance Access publication June 1, 29 Pharmacokinetic models for propofol defining and illuminating the devil in the detail A. R.
More informationTime to Lowest BIS after an Intravenous Bolus and an Adaptation of the Time-topeak-effect
Adjustment of k e0 to Reflect True Time Course of Drug Effect by Using Observed Time to Lowest BIS after an Intravenous Bolus and an Adaptation of the Time-topeak-effect Algorithm Reported by Shafer and
More informationThe importance of clearance
The importance of clearance The calculation of clearance can be especially useful in optimizing dosing of patients The clearance includes both the volume of distribution and the elimination rate The clearance
More informationRichard A. Beers, M.D. Professor, Anesthesiology SUNY Upstate Medical Univ VA Medical Center Syracuse, NY
Richard A. Beers, M.D. Professor, Anesthesiology SUNY Upstate Medical Univ VA Medical Center Syracuse, NY beersr@verizon.net 2 Improvements in safety and advances in care are re-invested in older, sicker
More informationApplications for Anaesthesia. arcomed syringe and infusion pumps
Applications for Anaesthesia arcomed syringe and infusion pumps TIVA TCI PCA PCEA PCS PIEB Anaesthesia programs and applications for arcomed Infusion Devices TIVA TCI PCA PCEA PCS PIEB (Total Intravenous
More informationEUROANESTHESIA 2006 BASIC PHARMACOKINETICS FOR THE CLINICIAN INTRODUCTION BASIC PARAMETERS COMPARTMENTAL MODELS. Madrid, Spain, 3-6 June RC2
BASIC PHARMACOKINETICS FOR THE CLINICIAN EUROANESTHESIA 2006 Madrid, Spain, 3-6 June 2006 9RC2 THOMAS W. SCHNIDER Institute for Anesthesiology Kantonsspital St.Gallen, Switzerland CHARLES F. MINTO Department
More informationCover Page. The handle holds various files of this Leiden University dissertation.
Cover Page The handle http://hdl.handle.net/1887/20616 holds various files of this Leiden University dissertation. Author: Lichtenbelt, Bart Jan Title: PK-PD modelling of the interaction of propofol and
More informationPHA Final Exam Fall 2006
PHA 5127 Final Exam Fall 2006 On my honor, I have neither given nor received unauthorized aid in doing this assignment. Name Please transfer the answers onto the bubble sheet. The question number refers
More informationAre We Safely Dosing Medications in Obese Children? Geisinger Health System Bloomsburg University School of Nurse Anesthesia Kasie Worley, SRNA
Are We Safely Dosing Medications in Obese Children? Geisinger Health System Bloomsburg University School of Nurse Anesthesia Kasie Worley, SRNA Target Objectives Review the basics of pharmacokinetic
More informationLippincott Questions Pharmacology
Lippincott Questions Pharmacology Edition Two: Chapter One: 1.Which one of the following statements is CORRECT? A. Weak bases are absorbed efficiently across the epithelial cells of the stomach. B. Coadministration
More informationTotal Intravenous Anaesthesia
Total Intravenous Anaesthesia Balasubramanian Thiagarajan Stanley Medical College Abstract: Total intravenous anaesthesia (TIVA) is a technique of anaesthesia which involves use of intravenous drugs to
More informationPHA Case Studies V (Answers)
PHA 5128 Case Studies V (Answers) 1. A 100 kg patient is to be treated p.o. with sodium phenytoin capsules. Assuming a phenytoin volume of distribution of 0.7 L/kg, Km of 4 mg/l and Vmax of 7 mg/kg/day,
More informationBIOPHARMACEUTICS and CLINICAL PHARMACY
11 years papers covered BIOPHARMACEUTICS and CLINICAL PHARMACY IV B.Pharm II Semester, Andhra University Topics: Absorption Distribution Protein binding Metabolism Excretion Bioavailability Drug Interactions
More informationTotal. Intravenous. ANAESTHESIA using target contro. Elderly. MAC Critica ill. Obese. Col Acad. College of Anaesthesiologists,
Total Intravenous ANAESTHESIA using target contro controlled infusion A pocket p reference Elderly MAC Critically Critica ill O Obese College of Anaesthesiologists, Col Acad Academy of Medicine of Malaysia
More informationAUSTRALIAN PRODUCT INFORMATION REMIFENTANIL APOTEX (REMIFENTANIL HYDROCHLORIDE) POWDER FOR INJECTION
AUSTRALIAN PRODUCT INFORMATION REMIFENTANIL APOTEX (REMIFENTANIL HYDROCHLORIDE) POWDER FOR INJECTION 1 NAME OF THE MEDICINE Remifentanil (as hydrochloride) 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each
More informationTotal Intravenous Anesthesia (TIVA) and Target Controlled Infusions (TCI) in Children
Curr Anesthesiol Rep (2013) 3:37 41 DOI 10.1007/s40140-012-0005-2 PEDIATRIC ANESTHESIA (J LERMAN, SECTION EDITOR) Total Intravenous Anesthesia (TIVA) and Target Controlled Infusions (TCI) in Children Neil
More informationPharmacology of intravenous induction agents
Pharmacology of intravenous induction agents Ákos Csomós MD, PhD Professor, Head of Department Medical Centre, Hungarian Defence Force, Budapest What do we have in the market? Thiopental Metohexital Etomidate
More informationChildhood Obesity: Anesthetic Implications
Childhood Obesity: Anesthetic Implications The Changing Practice of Anesthesia 2015 UCSF Department of Anesthesia and Perioperative Care Marla Ferschl, MD Associate Professor of Anesthesia University of
More informationName: UFID: PHA Exam 2. Spring 2013
PHA 5128 Exam 2 Spring 2013 1 Carbamazepine (5 points) 2 Theophylline (10 points) 3 Gentamicin (10 points) 4 Drug-drug interaction (5 points) 5 Lidocaine (5 points) 6 Cyclosporine (5 points) 7 Phenobarbital
More informationVolume of Distribution. Objectives. Volume of Distribution
1 Volume of Distribution Nick Holford Dept Pharmacology & Clinical Pharmacology University of Auckland, New Zealand 2 Objectives Learn the definition of volume of distribution Understand the physiological
More informationAnalgesia is a labeled indication for all of the approved drugs I will be discussing.
Comparative Opioid Pharmacology Disclosure Analgesia is a labeled indication for all of the approved drugs I will be discussing. I ve consulted with Glaxo (remifentanil), Abbott (remifentanil), Janssen
More informationBasic Pharmacokinetic Principles Stephen P. Roush, Pharm.D. Clinical Coordinator, Department of Pharmacy
Basic Pharmacokinetic Principles Stephen P. Roush, Pharm.D. Clinical Coordinator, Department of Pharmacy I. General principles Applied pharmacokinetics - the process of using drug concentrations, pharmaco-kinetic
More informationPHARMACOKINETICS SMALL GROUP I:
PHARMACOKINETICS SMALL GROUP I: Question 1 Absorption of the anti-fungal agent, itraconazole, is dependent on a low gastric ph. Calculate the relative concentrations of a weak acid (with a pka of 5.4)
More informationDrug dosing in Extremes of Weight
Drug dosing in Extremes of Weight The Plump & Heavy versus The Skinny & Light Maria Minerva P. Calimag, MD, MSc, PhD, DPBA, FPSECP PROFESSOR Departments of Pharmacology, Anesthesiology and Clinical Epidemiology
More informationPHA Final Exam. Fall On my honor, I have neither given nor received unauthorized aid in doing this assignment.
PHA 5127 Final Exam Fall 2010 On my honor, I have neither given nor received unauthorized aid in doing this assignment. Name Please transfer the answers onto the bubble sheet. The question number refers
More informationMultiple IV Bolus Dose Administration
PHARMACOKINETICS Multiple IV Bolus Dose Administration ١ Multiple IV Bolus Dose Administration Objectives: 1) To understand drug accumulation after repeated dose administration 2) To recognize and use
More informationDelayed Drug Effects. Distribution to Effect Site. Physiological Intermediate
1 Pharmacodynamics Delayed Drug Effects In reality all drug effects are delayed in relation to plasma drug concentrations. Some drug actions e.g. anti-thrombin III binding and inhibition of Factor Xa by
More informationPHA Spring First Exam. 8 Aminoglycosides (5 points)
PHA 5128 Spring 2012 First Exam 1 Aminoglycosides (5 points) 2 Aminoglycosides (10 points) 3 Basic Principles (5 points) 4 Basic Principles (5 points) 5 Bioavailability (5 points) 6 Vancomycin (5 points)
More informationDetermination of bioavailability
Pharmaceutics 2 Bioavailability Bioavailability is the rate and extent to which an administered drug reaches the systemic circulation. For example, if 100 mg of a drug is administered orally and 70 mg
More informationLD = (Vd x Cp)/F (Vd x Cp)/F MD = (Css x CL x T)/F DR = (Css x (Vm-DR))/Km Css = (F x D)/(CL x T) (Km x DR)/(Vm DR)
PHARMKIN WORKSHOP A PHARMACOKINETICS TEACHING SIMULATION Joseph K. Ritter, Ph.D. Associate Professor, Pharmacology and Toxicology MSB 536, 828-1022, jritter@mail2.vcu.edu Tompkins-McCaw Libray Room 2-006
More informationPharmacokinetics Overview
Pharmacokinetics Overview Disclaimer: This handout and the associated lectures are intended as a very superficial overview of pharmacokinetics. Summary of Important Terms and Concepts - Absorption, peak
More informationWHY... 8/21/2013 LEARNING OUTCOMES PHARMACOKINETICS I. A Absorption. D Distribution DEFINITION ADME AND THERAPEUIC ACTION
PHARMACOKINETICS I Absorption & Distribution LEARNING OUTCOMES By the end of the lecture students will be able to.. Dr Ruwan Parakramawansha MBBS, MD, MRCP(UK),MRCPE, DMT(UK) (2013/08/21) Define pharmacokinetics,
More informationPHA 5128 Final Exam Spring 2004 Version A. On my honor, I have neither given nor received unauthorized aid in doing this assignment.
PHA 5128 Final Exam Spring 2004 Version A On my honor, I have neither given nor received unauthorized aid in doing this assignment. Name There are 18 questions. Total /120 pts Final 2004 1 1. T.P., a 66-year-old,
More informationPHA Final Exam. Fall On my honor, I have neither given nor received unauthorized aid in doing this assignment.
PHA 5127 Final Exam Fall 2012 On my honor, I have neither given nor received unauthorized aid in doing this assignment. Name Please transfer the answers onto the bubble sheet. The question number refers
More informationPharmacokinetic Calculations
Pharmacokinetic Calculations Introduction. Pharmacokinetics involves the relationship between concentration of drug (and its metabolites), measured most often in plasma, drug dosage, and time. A vast majority
More informationGeneral Principles of Pharmacology and Toxicology
General Principles of Pharmacology and Toxicology Parisa Gazerani, Pharm D, PhD Assistant Professor Center for Sensory-Motor Interaction (SMI) Department of Health Science and Technology Aalborg University
More informationPharmacokinetics of strong opioids. Susan Addie Specialist palliative care pharmacist
Pharmacokinetics of strong opioids Susan Addie Specialist palliative care pharmacist What is the difference between pharmacokinetics and pharmacodynamics? Definitions Pharmacokinetics = what the body does
More informationComparative study of effective-site target controlled infusion with standard bolus induction of propofol for laryngeal mask airway insertion
Asian Biomedicine Vol. 4 No. 1 February 2010; 177-182 Brief communication (Original) Comparative study of effective-site target controlled infusion with standard bolus induction of propofol for laryngeal
More informationPHARMACOKINETICS SMALL GROUP II:
PHARMACOKINETICS SMALL GROUP II: Question 1 Why are some drug therapies initiated with a loading dose? Emphasize that LD establishes initial therapeutic level quickly. The time to reach the steady-state
More informationPharmacokinetics One- compartment Open Model Lec:2
22 Pharmacokinetics One- compartment Open Model Lec:2 Ali Y Ali BSc Pharmacy MSc Industrial Pharmaceutical Sciences Dept. of Pharmaceutics School of Pharmacy University of Sulaimani 1 Outline Introduction
More informationPHA 5128 Spring 2009 First Exam (Version B)
Name: UFID: PHA 5128 Spring 2009 First Exam (Version B) On my honor, I have neither given nor received unauthorized aid in doing this assignment. Print: Sign: Version B Q1: Phenytoin (10) Q2: procainamide
More informationCOMPARTMENTAL ANALYSIS OF DRUG DISTRIBUTION Juan J.L. Lertora, M.D., Ph.D. Director Clinical Pharmacology Program September 23, 2010
COMPARTMENTAL ANALYSIS OF DRUG DISTRIBUTION Juan J.L. Lertora, M.D., Ph.D. Director Clinical Pharmacology Program September 23, 2010 Office of Clinical Research Training and Medical Education National
More information1. Immediate 2. Delayed 3. Cumulative
1 Pharmacodynamic Principles and the Time Course of Delayed Drug Effects Nick Holford Dept Pharmacology & Clinical Pharmacology University of Auckland, New Zealand The time course of drug action combines
More informationTotal Intravenous Anesthesia
Total Intravenous Anesthesia A RATIONAL APPROACH TO ANESTHETIC MANAGEMENT Michael Rieker, DNP, CRNA, FAAN Director, Nurse Anesthesia Program Wake Forest School of Medicine Objectives Review drugs and methods
More informationPharmacokinetic concepts for TCI anaesthesia
Pharmacokinetic concepts for TCI anaesthesia E. Gepts Department of Anaesthesiology, UVC Sint Pieter, 322 Hoogstraat, 1000 Brussels, Belgium Summary The development of new short-acting anaesthetic drugs,
More informationDRUG DISTRIBUTION. Distribution Blood Brain Barrier Protein Binding
DRUG DISTRIBUTION Distribution Blood Brain Barrier Protein Binding DRUG DISTRIBUTION Drug distribution is a reversible transport of drug through the body by the systemic circulation The drug molecules
More informationKetofol: risky or revolutionary: CPD article IV
Ketofol: risky or revolutionary: CPD article IV Abstract Ketofol, a sedative/analgesic combination of ketamine and propofol, which can be administered as a mixture in the same syringe or independently,
More informationBasic Pharmacokinetics and Pharmacodynamics: An Integrated Textbook with Computer Simulations
Basic Pharmacokinetics and Pharmacodynamics: An Integrated Textbook with Computer Simulations Rosenbaum, Sara E. ISBN-13: 9780470569061 Table of Contents 1 Introduction to Pharmacokinetics and Pharmacodynamics.
More informationPHA 4120 Second Exam Key Fall On my honor, I have neither given nor received unauthorized aid in doing this assignment.
PHA 4120 Second Exam Key Fall 1997 On my honor, I have neither given nor received unauthorized aid in doing this assignment. Name Question Points 1. /10 ponts 2. /20 points 3. /10 points 4. /10 points
More informationULTIVA GlaxoSmithKline
ULTIVA GlaxoSmithKline Remifentanil QUALITATIVE AND QUANTITATIVE COMPOSITION Remifentanil for injection is a sterile, endotoxin-free, preservative-free, white to off white, lyophilised powder, to be reconstituted
More informationPHA 5128 Spring 2000 Final Exam
PHA 128 Spring 2000 Final Exam On my honor, I have neither given nor received unauthorized aid in doing this assignment. Name TYPED KEY Questions Points 1. /1 2. /1 3. /1 4. /1. /10 6. /10. /10 8. /10
More informationEstimation of effect site concentration of propofol for laryngeal mask airway insertion using fentanyl or morphine as adjuvant
Clinical Investigation Estimation of effect site concentration of propofol for laryngeal mask airway insertion using fentanyl or morphine as adjuvant Address for correspondence: Dr. Kusha Nag, Department
More informationULTIVA. Remifentanil hydrochloride
ULTIVA Remifentanil hydrochloride QUALITATIVE AND QUANTITATIVE COMPOSITION Remifentanil for injection is a sterile, preservative-free, white to off white, lyophilised powder, to be reconstituted before
More informationSection 5.2: Pharmacokinetic properties
Section 5.2: Pharmacokinetic properties SmPC training presentation Note: for full information refer to the European Commission s Guideline on summary of product characteristics (SmPC) SmPC Advisory Group
More informationOP01 [Mar96] With regards to pethidine s physical properties: A. It has an octanol coefficient of 10 B. It has a pka of 8.4
Opioid MCQ OP01 [Mar96] With regards to pethidine s physical properties: A. It has an octanol coefficient of 10 B. It has a pka of 8.4 OP02 [Mar96] Which factor does NOT predispose to bradycardia with
More informationDrug Distribution. Joseph K. Ritter, Ph.D., Assoc. Prof. Medical Sciences Building, Room
Drug Distribution Joseph K. Ritter, Ph.D., Assoc. Prof. Medical Sciences Building, Room 531 jkritter@vcu.edu 828-1022 Department of Pharmacology and Toxicology Medical College of Virginia Campus Virginia
More informationMark D. Antoszyk, CRNA, BS Director Anesthesia Services Department of Anesthesiology Carolina s Medical Center Northeast Concord, North Carolina
Mark D. Antoszyk, CRNA, BS Director Anesthesia Services Department of Anesthesiology Carolina s Medical Center Northeast Concord, North Carolina Mark D. Antoszyk, CRNA, BS, is director of anesthesia services
More informationOptimization Methods to Minimize Emergence Time While Maintaining Adequate Post-Operative Analgesia
Optimization Methods to Minimize Emergence Time While Maintaining Adequate ost-operative Analgesia arl Tams BS, Noah Syroid MS, Ken B. Johnson MD, Talmage D. Egan MD, Dwayne Westenskow hd ABSTAT A rapid
More information1. If the MTC is 100 ng/ml and the MEC is 0.12 ng/ml, which of the following dosing regimen(s) are in the therapeutic window?
Page 1 PHAR 750: Biopharmaceutics/Pharmacokinetics October 23, 2009 - Form 1 Name: Total 100 points Please choose the BEST answer of those provided. For numerical answers, choose none of the above if your
More informationThus, we can group the entire loading dose together as though it was given as a single dose, all administered when the first dose was given.
PHA 5128 Dose Optimization II, Spring 2012, Case Study V Solution If you have any questions regarding this case study, do not hesitate to contact Benjamin Weber (benjaminweber@ufl.edu). Please remember
More informationREMIFENTANIL Alphapharm Remifentanil PRODUCT INFORMATION
REMIFENTANIL Alphapharm Remifentanil PRODUCT INFORMATION NAME OF THE MEDICINE Active ingredient : Remifentanil (as hydrochloride) Chemical name : 1-(2-Methoxycarbonyl-ethyl)-4-(phenylpropionyl-amino)-piperidine-4-carboxylic
More informationMed. Weter. 2018, 74 (7), DOI: dx.doi.org/ /mw.5988 BARBARA CUNIBERTI, VILHELMIINA HUUSKONEN, J.M. LYNNE HUGHES
466 Praca oryginalna DOI: dx.doi.org/10.21521/mw.5988 Original paper In vitro delivery accuracy of Computer Controlled Infusion Pump software linked to an Alaris GH syringe pump for propofol target-controlled
More informationTarget Controlled Infusions for Moderate Sedation in Dentistry
Alberta Dental Society of Anesthesiology Guest Articles Target Controlled Infusions for Moderate Sedation in Dentistry 1. History and Development of Target Controlled Infusion Sedation for Dentistry in
More informationPharmacokinetics of propofol when given by intravenous
Br. J. clin. Pharmac. (199), 3, 144-148 Pharmacokinetics of propofol when given by intravenous infusion DENIS J. MORGAN', GWEN A. CAMPBELL2,* & DAVID P. CRANKSHAW2 'Victorian College of Pharmacy, 381 Royal
More informationPharmacokinetics I. Dr. M.Mothilal Assistant professor
Pharmacokinetics I Dr. M.Mothilal Assistant professor DRUG TRANSPORT For a drug to produce a therapeutic effect, it must reach to its target and it must accumulate at that site to reach to the minimum
More informationPharmacodynamics & Pharmacokinetics 1
PCTH 325 Pharmacodynamics & Pharmacokinetics 1 Dr. Shabbits jennifer.shabbits@ubc.ca September 9, 2014 Learning objectives 1. Describe the categories of intended drug action 2. Compare and contrast agonists
More informationEffect-site concentration of remifentanil for laryngeal mask airway insertion during target-controlled infusion of propofol
doi:10.1111/j.1365-2044.2008.05707.x Effect-site concentration of remifentanil for laryngeal mask airway insertion during target-controlled infusion of propofol M. K. Kim, 1 J. W. Lee, 2 D. J. Jang, 3
More informationNontraditional PharmD Program PRDO 7700 Pharmacokinetics Review Self-Assessment
Nontraditional PharmD Program PRDO 7700 Pharmacokinetics Review Self-Assessment Please consider the following questions. If you do not feel confident about the material being covered, then it is recommended
More informationGeneral Pharmacology MCQs
General Pharmacology MCQs GP01 [Mar96] A drug is given at a dose of 50 mg/kg to a 70 kg man. The plasma concentration after giving it is 10 mg/ml. The elimination half-life is 8 hours. Clearance would
More informationCLINICAL PHARMACOKINETICS INDEPENDENT LEARNING MODULE
CLINICAL PHARMACOKINETICS INDEPENDENT LEARNING MODULE Joseph K. Ritter, Ph.D. Assoc. Professor, Pharmacology and Toxicology MSB 536, 828-1022, jritter@vcu.edu This self study module will reinforce the
More informationPHA5128 Dose Optimization II Case Study 3 Spring 2013
Use the vancomycin dosing nomogram table below: A female patient, 57 years of age, 5 6 in height and 100 in weight had an infection requiring vancomycin treatment. Her serum creatinine was 0.8 mg/d. What
More informationClinical Evaluation of Closed-Loop Administration of Propofol Guided by the NeuroSENSE Monitor in Children
Clinical Evaluation of Closed-Loop Administration of Propofol Guided by the van Heusden, Klaske; Dumont, Guy A.; Soltesz, Kristian; Petersen, Christian; West, Nicholas; Umedaly, Aryannah; Ansermino, J.
More informationInitiating Labour Analgesia in 2020: Predicting the Future Epidurals, CSEs, Spinal Catheters, Epidrum & Epiphany
Initiating Labour Analgesia in 2020: Predicting the Future Epidurals, CSEs, Spinal Catheters, Epidrum & Epiphany Kenneth E Nelson, M.D. Associate Professor Wake Forest University, North Carolina, USA Initiating
More informationPredictive performance of Servin s formula during BIS Ò -guided propofol-remifentanil target-controlled infusion in morbidly obese patients
British Journal of Anaesthesia 98 (1): 66 75 (27) doi:1.193/bja/ael321 Advance Access publication November 27, 26 Predictive performance of Servin s formula during BIS Ò -guided propofol-remifentanil target-controlled
More informationNonlinear Pharmacokinetics
Nonlinear Pharmacokinetics Non linear pharmacokinetics: In some cases, the kinetics of a pharmacokinetic process change from predominantly first order to predominantly zero order with increasing dose or
More informationDrug Disposition in Obesity & Protein-Calorie Malnutrition
Drug Disposition in Obesity & Protein-Calorie Malnutrition JBoullata, PharmD, RPh, BCNSP Associate Professor of Pharmacology & Therapeutics -and- Pharmacy Specialist in Nutrition Support University of
More informationTamer Barakat. Abdul Aziz ALShamali. Abdul Aziz ALShamali
10 Tamer Barakat Abdul Aziz ALShamali Abdul Aziz ALShamali Dr. Alia Elimination: Refampin is used to treat TB not malaria (Quinacrine is used for malaria) It s the opposite process of absorption. It's
More informationPharmacokinetics. Karim Rafaat
Pharmacokinetics Karim Rafaat Pharmacokinetics The therapeutic effect of a drug is determined by the concentration of drug at the receptor site of action. Even though the concentration of drug that reaches
More informationRational Dose Prediction. Pharmacology. φαρμακον. What does this mean? pharmakon. Medicine Poison Magic Spell
1 Rational Dose Prediction Nick Holford Dept Pharmacology & Clinical Pharmacology University of Auckland, New Zealand 2 Pharmacology Pharmacology is derived from a Greek word (pharmakon). The Greeks used
More informationDoses Target Concentration Intervention
1 Doses Target Concentration Intervention 2 Problem 1 Questions 1-2 Susan is a 28 year old woman who has had epilepsy since she was 5 years old. She has been on, and off, anticonvulsant medication since
More informationBASIC PHARMACOKINETICS
BASIC PHARMACOKINETICS MOHSEN A. HEDAYA CRC Press Taylor & Francis Croup Boca Raton London New York CRC Press is an imprint of the Taylor & Francis Group, an informa business Table of Contents Chapter
More informationChapter-V Drug use in renal and hepatic disorders. BY Prof. C.Ramasamy, Head, Dept of Pharmacy Practice SRM College of Pharmacy, SRM University
Chapter-V Drug use in renal and hepatic disorders. BY Prof. C.Ramasamy, Head, Dept of Pharmacy Practice SRM College of Pharmacy, SRM University Estimating renal function An accurate estimation of renal
More informationC OBJECTIVES. Basic Pharmacokinetics LESSON. After completing Lesson 2, you should be able to:
LESSON 2 Basic Pharmacokinetics C OBJECTIVES After completing Lesson 2, you should be able to: 1. Define the concept of apparent volume of distribution and use an appropriate mathematical equation to calculate
More informationPharmacokinetic Models Using Ordinary Differential Equations* DRUG DISTRIBUTION COMPARTMENTAL ANALYSIS OF DRUG DISTRIBUTION
COMPARTMENTAL ANALYSIS OF DRUG DISTRIBUTION Juan J.L. Lertora, M.D., Ph.D. Director Clinical Pharmacology Program September 10, 2015 Office of Clinical Research Training and Medical Education National
More informationSedation For Cardiac Procedures A Review of
Sedation For Cardiac Procedures A Review of Sedative Agents Dr Simon Chan Consultant Anaesthesiologist Department of Anaesthesia and Intensive Care Prince of Wales Hospital Hong Kong 21 February 2009 Aims
More informationCase Study 2 Answers Spring 2006
Case Study 2 Answers Spring 2006 1. The volume of distribution of diazepam in a group of normal subjects (60 kg, ideal body weight) was found to be 105 L. In another group of patients (110 kg), the volume
More informationTDM Lecture 7 5 th Stage. TDM of Digoxin. Uses: Digoxin is usually used in heart failure associated and atrial fibrillation.
TDM Lecture 7 5 th Stage TDM of Digoxin Digoxin uses and elimination Uses: Digoxin is usually used in heart failure associated and atrial fibrillation. Elimination: About 75% of digoxin clearance occurred
More informationBiopharmaceutics Lecture-11 & 12. Pharmacokinetics of oral absorption
Biopharmaceutics Lecture-11 & 12 Pharmacokinetics of oral absorption The systemic drug absorption from the gastrointestinal (GI) tract or from any other extravascular site is dependent on 1. 2. 3. In the
More informationThe general Concepts of Pharmacokinetics
The general Concepts of Pharmacokinetics What is this jargon? Is it useful? C max, clearance, Vd, half-life, AUC, bioavailability, protein binding F. Van Bambeke, E. Ampe, P.M. Tulkens (Université catholique
More information8/26/14. Disclosures. Objectives. None
Disclosures None Objectives Understand Importance of Pediatric Obesity Impact on Physiology Preoperative Assessment Intra-operative Management PACU & the obese pediatric Patient 1 Gender specific charts
More informationproblems with, 29, 98 psychiatric patients, 96 rheumatic conditions, 97
180 ACE inhibitors, 26 acetaminophen, see paracetamol acupressure, anti-emetic effect, 143 acute drugs, 64 5 adenoidectomy, 161 adrenaline, 64 α-2-chloroprocaine, 74, 81 age impact on patient selection,
More informationPHA 5128 CASE STUDY 5 (Digoxin, Cyclosporine, and Methotrexate) Spring 2007
PHA 5128 CASE STUDY 5 (Digoxin, Cyclosporine, and Methotrexate) Spring 2007 1. L.J., a 30 year old male, was diagnosed congestive heart failure (CHF). He is 5'9" tall and weights 80 kg. He was given Furosemide
More informationADME Review. Dr. Joe Ritter Associate Professor of Pharmacology
ADME Review Dr. Joe Ritter Associate Professor of Pharmacology 828-1022 jkritter@vcu.edu What percent of a weak base (pka = 7.5) and weak acid (pka = 3.5) will be respectively ionized in urine of ph 5.5?
More informationCover Page. The handle holds various files of this Leiden University dissertation.
Cover Page The handle http://hdl.handle.net/1887/2959 holds various files of this Leiden University dissertation. Author: Diepstraten, Jeroen Title: The influence of morbid obesity on the pharmacokinetics
More informationCorrection of target-controlled infusion following wrong selection of emulsion concentrations of propofol
Experimental Research Article Korean J Anesthesiol 2014 May 66(5): 377-382 http://dx.doi.org/10.4097/kjae.2014.66.5.377 Correction of target-controlled infusion following wrong selection of emulsion concentrations
More information